Randomized trial data support the use of either TNF or IL-17 inhibitors to treat axial spondyloarthritis, based on patient ...

The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a ...

A simple blood test can pick up cancer cases among patients who have been falsely reassured they do not have the disease, a study suggests. Experts from the University of Oxford and the diagnostics ...

WATERTOWN, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the ...

A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

Two patients previously admitted to the University of Washington Medical Center-Northwest have tested positive for Candida auris, a drug-resistant fungus that has become a growing concern in ...

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes ...

PreliminaryResultsYield43%OverallResponseRates(viaRECIST)intheEfficacyPopulation DataDemonstrateREM-422,theFirst-in-ClassSmallMoleculeMYBmRNADegrader,Reduces ...

GENEVA--(BUSINESS WIRE)--Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a ...